There are commercial access agreements for enfortumab vedotin and pembrolizumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Fertility clinics should not offer unproven treatments that don't help people have babies, our independent committee has recommended in draft guidance.

In the lead-up to World Duchenne Awareness Day (Sunday, 7 September), we’re pleased to announce the completion of our first assessment of an externally developed clinical guideline – marking a ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Our health technology evaluation manual explains how we carry out health technology evaluations. It includes both the processes we use and the methods, as well as the principles and considerations ...

Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.

This guideline covers nutrition and weight management in pregnancy for anyone who may become pregnant, is planning to become pregnant or is already pregnant, and nutrition in children up to 5 years.

Evidence-based recommendations on elranatamab (Elrexfio) for treating relapsed and refractory multiple myeloma after 3 or more treatments in adults. Next review: More evidence on elranatamab is being ...

We provide access to a range of journals, databases and other evidence-based resources for health and social care staff in England. You'll need an NHS OpenAthens account to access most of these ...

Why are we doing this? Both patients and healthcare professionals can benefit from having a range of technologies to choose from. The Medicines and Healthcare Regulatory Agency (MHRA) has over 3 ...

Antimicrobial resistance (AMR) is an urgent global challenge. AMR causes around 700,000 deaths each year globally. That number is predicted to rise to 10 million by 2050 if no action is taken.

There is a simple discount patient access scheme for etrasimod. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...